0 followers
Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Stephen J. Russell
Summit Therapeutics
4 followers
Pivot Bio
2 followers
Generation Bio
2 followers
ALS Therapy Development Institute
3 followers
Genesis Therapeutics
3 followers
Carisma Therapeutics
1 follower
Genentech
160 followers
Gilead Sciences
135 followers
Agilent Technologies
69 followers
Neuralink
62 followers
Verily Life Sciences
38 followers
Explore companies